Solumed Centrum Medyczne | Poznan, Poland
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to compare the efficacy and safety of daily and every other day dosing of rimegepant to placebo as a preventive treatment for episodic migraine.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Sex and Reproductive Status:
Prohibited Medications:
Primary purpose
Allocation
Interventional model
Masking
695 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Pfizer Pfizer CT.gov Call Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal